Tci Wealth Advisors, Inc. Insmed Inc Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$16.26 - $21.73 $2,097 - $2,803	-129 Reduced 99.23%	1 $0
Q4 2022 Feb 06, 2023	SELL	$16.98 - $23.15 $696 - $949	-41 Reduced 23.98%	130 $2,000
Q2 2022 Jul 19, 2022	SELL	$17.07 - $25.71 $2,304 - $3,470	-135 Reduced 44.12%	171 $3,000
Q1 2022 Apr 29, 2022	BUY	$20.42 - $28.13 $2,348 - $3,234	115 Added 60.21%	306 $7,000
Q4 2021 Jan 24, 2022	SELL	$25.89 - $33.45 $854 - $1,103	-33 Reduced 14.73%	191 $5,000
Q3 2021 Oct 29, 2021	BUY	$22.46 - $29.47 $3,009 - $3,948	134 Added 148.89%	224 $6,000
Q2 2021 Aug 02, 2021	SELL	$24.17 - $36.01 $459 - $684	-19 Reduced 17.43%	90 $3,000
Q1 2021 Apr 29, 2021	BUY	$32.28 - $44.3 $3,518 - $4,828	109 New	109 $4,000

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.